Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Nicotinamide riboside (NR) is in wide use as an NAD + precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD + metabolism in humans. We report that human blood NAD + can rise as much as 2.7-fold with a single oral dose of NR in a pilot study of one individual, and that oral NR elevates mouse hepatic NAD + with distinct and superior pharmacokinetics to those of nicotinic acid and nicotinamide. We further show that single doses of 100, 300 and 1,000 mg of NR produce dose-dependent increases in the blood NAD + metabolome in the first clinical trial of NR pharmacokinetics in humans. We also report that nicotinic acid adenine dinucleotide (NAAD), which was not thought to be en route for the conversion of NR to NAD + , is formed from NR and discover that the rise in NAAD is a highly sensitive biomarker of effective NAD + repletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NAM, in contrast, is a well reported and widely used sirtuin inhibitor31 and has been recently shown to inhibit NAD+-consuming activities in vivo24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In another study, NAAD was not detected in human blood prior to NR supplementation, while there was a ∼2,900% increase in NAAD baseline in healthy individuals taking single doses of up to 1 g NR (100, 300, and 1000 mg) [63].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“It is still unclear why NR administration increases NAD+ levels more than NAM and NA treatment [63], while NMN and NAM administration showed no difference in NAD levels in blood and liver [90].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, by LC-tandem MS and with the use of internal standards, the baseline concentrations of hepatic NMN and NAD+ were determined to be ∼2 and ∼1,000 pmol mg−1, respectively, rising to ∼10 and ∼4,000 pmol mg−1, respectively, 6 h after oral gavage of 185 mg kg−1 NR24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“This concept was established by a recent study in which orally administered equimolar NAM, NR and NA produced unique effects on hepatic NAD+ metabolism through distinct biosynthetic routes24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan‐Ling, T., Guillemin, G. J., Smythe, G. A., & Sachdev, P. S. (2013) · Biogerontology · doi:10.1007/s10522-013-9489-5 · Cited by 126
RetractedDose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C.-X., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Research works printed but not linked: 1
- Altman, L. K. Who Goes First: The Story of Self-experimentation in Medicine University of California Press (1987).
Cited by
Items 201–300 of 696
NMNAT2 is a druggable target to drive neuronal NAD production
Tribble, J. R., Jöe, M., Varricchio, C., Otmani, A., Canovai, A., Habchi, B., Daskalakis, E., Chaleckis, R., Loreto, A., Gilley, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50354-5 · Cited by 50
“Whilst nicotinamide riboside (NR) can achieve greater (although more transient) NAD increases than nicotinamide at lower doses 33 , its utility in the retina is more limited due to the low expression of NRK (required to convert NR to NMN 6 ) which produces only a modest 10 – 20% NAD increase 34 .”
Deficiency of the Mitochondrial NAD Kinase Causes Stress-Induced Hepatic Steatosis in Mice
Zhang, K., Kim, H., Fu, Z., Qiu, Y., Yang, Z., Wang, J., Zhang, D., Tong, X., Yin, L., Li, J., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.09.010 · Cited by 52
NAD (P) HX repair deficiency causes central metabolic perturbations in yeast and human cells
Becker‐Kettern, J., Paczia, N., Conrotte, J., Zhu, C., Fiehn, O., Jung, P. P., Steinmetz, L. M., & Linster, C. L. (2018) · FEBS Journal · doi:10.1111/febs.14631 · Cited by 45
“The former cause may be more straightforward to address, notably by supplementation of NAD precursor vitamins such as nicotinic acid, nicotinamide or nicotinamide riboside [55].”
BackgroundEffect of NAD+ boosting on kidney ischemia-reperfusion injury
Morevati, M., Egstrand, S., Nordholm, A., Mace, M. L., Andersen, C. B., Salmani, R., Ølgaard, K., & Lewin, E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252554 · Cited by 47
“Furthermore, NR has been shown to be more efficient in boosting NAD+ than other NAD+ precursors such as NAM [83,84], possibly due to increased intestinal uptake [85,86].”
BackgroundMulti-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism
Klimova, N., & Kristián, T. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02729-0 · Cited by 43
Orlandi, I., Alberghina, L., & Vai, M. (2020) · Biomolecules · doi:10.3390/biom10040604 · Cited by 42
Implications of NAD+ Metabolism in the Aging Retina and Retinal Degeneration
Jadeja, R. N., Thounaojam, M. C., Bartoli, M., & Martin, P. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2692794 · Cited by 48
Restoring aged stem cell functionality: Current progress and future directions
Spehar, K., Pan, A., & Beerman, I. (2020) · Stem Cells · doi:10.1002/stem.3234 · Cited by 41
Simic, P., Vela Parada, X. F., Parikh, S. M., Dellinger, R., Guarente, L. P., & Rhee, E. P. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02006-1 · Cited by 42
“Thus in retrospect, the initial goal of a 50 to 100% increase in NAD levels was likely set too high, in large part because it was based on studies in healthy volunteers [10, 11] without accounting for such a profound decrease in whole blood NAD levels with kidney injury (50% decrease after 2 days of AKI).”
BackgroundInfluentialSelf-citationYaku, K., Palikhe, S., Iqbal, T., Hayat, F., Watanabe, Y., Fujisaka, S., Izumi, H., Yoshida, T., Karim, M., Uchida, H., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr1538 · Cited by 40
“A previous study proposed that orally administered NR was directly absorbed from the intestine as an intact form and converted to NMN by NRK inside cells ( 11 , 60 ).”
Self-citationNAD+ Precursors: A Questionable Redundancy
Cantó, C. (2022) · Metabolites · doi:10.3390/metabo12070630 · Cited by 44
Host–microbiome interactions in nicotinamide mononucleotide (NMN) deamidation
Kim, L., Chalmers, T. J., Madawala, R. J., Smith, G. C., Li, C., Das, A., Poon, E. W. K., Wang, J., Tucker, S. P., Sinclair, D. A., et al. (2023) · FEBS Letters · doi:10.1002/1873-3468.14698 · Cited by 48
Badawy, A. A. ‐. (2023) · Bioscience Reports · doi:10.1042/bsr20230595 · Cited by 44
“Whereas nicotinamide riboside (NAMR) is equally effective in increasing levels of NAD + (P + ) as nicotinamide, it is 3-fold more active in increasing the ADP-ribose product of the PARP and SIRT reactions [155], an undesirable effect as PARPs are already activated by COVID-19.”
BackgroundWalker, M. A., Chen, H., Yadav, A. S., Ritterhoff, J., Villet, O. M., McMillen, T. S., Wang, Y., Purcell, H. J., Djukovic, D., Raftery, D., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.066039 · Cited by 43
Norheim, K. L., Ezra, M. B., Heckenbach, I., Andreasson, L. M., Eriksen, L. L., Dyhre‐Petersen, N., Damgaard, M. V., Berglind, M., Pricolo, L., Sampson, D. L., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00758-1 · Cited by 53
Self-citationBalancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Cercillieux, A., Ciarlo, E., & Cantó, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04499-5 · Cited by 42
“Later work showed how NR could increase NAD+ levels in cultured mammalian cells [151], rodent tissues [152] and peripheral blood mononuclear cells in humans after oral administration [153].”
Background(2020) · doi:10.1101/2020.09.10.289561 · Cited by 41
“Given that NMN and NR are overwhelmingly incorporated in the form of free Nam, why do the downstream biological effects of NR or NMN differ from the delivery of free Nam (Trammell et al., 2016), a widely available nutrient present in dietary sources? One basic assumption is that exogenous NAD+ precursors increase leve…”
BackgroundInfluentialA systems-approach to NAD+ restoration
Conlon, N. J., & Ford, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114946 · Cited by 47
Biţă, A., Scorei, I. R., Ciocîlteu, M. V., Nicolaescu, O. E., Pîrvu, A. S., Bejenaru, L. E., Rău, G., Bejenaru, C., Radu, A., Neamţu, J., et al. (2023) · Molecules · doi:10.3390/molecules28166078 · Cited by 36
“The first clinical trial of NR PK in healthy humans highlighted that 100, 300, and 1000 mg of NR single dose increased the NAD+ metabolome in a dose-dependent manner [231].”
BackgroundArsiwala, T., Pahla, J., van Tits, L. J., Bisceglie, L., Gaul, D. S., Costantino, S., Miranda, M. X., Nussbaum, K., Stivala, S., Błyszczuk, P., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.01.002 · Cited by 43
Gerasimenko, M., Михайлович, Ч. С., Furuhara, K., Lopatina, O. L., Salmina, A. B., Shabalova, A. A., Tsuji, C., Yokoyama, S., Ishihara, K., Brenner, C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-57236-7 · Cited by 43
Self-citationMaintenance of NAD+ Homeostasis in Skeletal Muscle during Aging and Exercise
Ji, L. L., & Yeo, D. (2022) · Cells · doi:10.3390/cells11040710 · Cited by 40
“Several recent review articles summarized and compared the bioavailability, pharmacokinetic, and pharmacological properties of NA, NAM, NMN, and NR [36,49,50].”
BackgroundThe emergence of the nicotinamide riboside kinases in the regulation of NAD+ metabolism
Fletcher, R. S., & Lavery, G. G. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0085 · Cited by 44
Kourtzidis, I. A., Dolopikou, C. F., Tsiftsis, A. N., Margaritelis, N. V., Theodorou, A. A., Zervos, I. A., Tsantarliotou, M. P., Veskoukis, A. S., Vrabas, I. S., Paschalis, V., et al. (2018) · Experimental Physiology · doi:10.1113/ep086964 · Cited by 41
Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity
Dall, M., Trammell, S. A. J., Asping, M., Hassing, A. S., Agerholm, M., Vienberg, S. G., Gillum, M. P., Larsen, S., & Treebak, J. T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006756 · Cited by 45
“NR-(13)C,d was synthesized as described (33) and kindly provided by Prof.”
MethodInfluentialSelf-citationZhang, X., Zhang, N., Chrenek, M. A., Girardot, P. E., Wang, J., Sellers, J. T., Geisert, E. E., Brenner, C., Nickerson, J. M., Boatright, J. H., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13060893 · Cited by 40
“A mouse and human study comparing NR and NAM reported superior bioavailability for NR for both species [31].”
BackgroundSelf-citationSirtuin Modulators in Cellular and Animal Models of Human Diseases
Hong, J. Y., & Lin, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.735044 · Cited by 43
“Adding precursors of NAD like nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN) to the cells increased the overall NAD level, thereby activating sirtuins (Bonkowski and Sinclair, 2016; Trammell et al., 2016).”
BackgroundTaechameekietichai, T., Chansangpetch, S., Peerawaranun, P., & Lin, S. C. (2021) · Nutrients · doi:10.3390/nu13124263 · Cited by 42
“As nicotinamide riboside has better bioavailability than NAM in humans [53], and is safe and well-tolerated [54–56].”
BackgroundA Method to Monitor the NAD+ Metabolome—From Mechanistic to Clinical Applications
Giner, M. P., Christen, S., Bártová, S., Makarov, M. V., Migaud, M. E., Cantó, C., & Moco, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910598 · Cited by 39
“These findings are in agreement with previous reports in which NAD+ was detected in whole blood [21,28,39,40], red blood cells (RBCs) [41] and peripheral blood mononuclear cells (PBMCs) [38], but not in plasma.”
BackgroundResultSelf-citationDiscovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Wilsbacher, J. L., Cheng, M., Cheng, D., Trammell, S. A. J., Shi, Y., Guo, J. Q., Koeniger, S. L., Kovar, P. J., He, Y., Selvaraju, S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0819 · Cited by 39
Self-citationMenni, C., Migaud, M. E., Kastenmüller, G., Pallister, T., Zierer, J., Peters, A., Mohney, R. P., Spector, T. D., Bagnardi, V., Gieger, C., et al. (2017) · Obesity · doi:10.1002/oby.21922 · Cited by 42
“It also suggests that the metabolites identified in our study might be used to monitor the efficacy of therapies aimed at restoring mitochondrial function, such as ongoing clinical trials using nicotinamide adenine dinucleotide precursors (39).”
BackgroundSelf-citationImmunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide
Badawy, A. A. ‐. (2020) · Bioscience Reports · doi:10.1042/bsr20202856 · Cited by 40
Higgins, C. B., Mayer, A. L., Zhang, Y., Franczyk, M. P., Ballentine, S. J., Yoshino, J., & DeBosch, B. J. (2022) · Nature Communications · doi:10.1038/s41467-022-28717-7 · Cited by 43
Nie, H., Zhang, Y., Yu, H., Xiao, H., Li, T., & Yang, Q. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1886198 · Cited by 39
“Nicotinamide riboside (NR) is a pyridine nucleoside form of vitamin B3, which naturally exists in milk and is a candidate of dietary supplement (Trammell et al., 2016; Martens et al., 2018).”
BackgroundCurrent Uncertainties and Future Challenges Regarding NAD+ Boosting Strategies
Poljšak, B., Kovač, V., & Milisav, I. (2022) · Antioxidants · doi:10.3390/antiox11091637 · Cited by 52
Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial
McDermott, M. M., Martens, C. R., Domanchuk, K. J., Zhang, D., Peek, C. B., Criqui, M. H., Ferrucci, L., Greenland, P., Guralnik, J. M., Ho, K. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49092-5 · Cited by 49
“Inhumans,oralNR increased NAD+ abundance 15,16 .”
Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing
Broome, S. C., Whitfield, J., Karagounis, L. G., & Hawley, J. A. (2024) · Sports Medicine · doi:10.1007/s40279-024-02072-7 · Cited by 47
Shi, W., Hegeman, M. A., Doncheva, A. I., Bekkenkamp‐Grovenstein, M., de Boer, V. C. J., & Keijer, J. (2019) · Nutrients · doi:10.3390/nu11102439 · Cited by 38
“Levels of nicotinic acid adenine dinucleotide (NAAD) and N-methyl-4-pyridone-5-carboxamide (Me4py) in the liver were quantified as described [14,25].”
BackgroundMethodMa, S., Feng, J. H., Lin, X., Liu, J., Tang, Y., Nie, S., Gong, J., & Wang, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5546867 · Cited by 40
“7-fold, demonstrating the feasibility of NAD supplementation for the human patient [23].”
BackgroundYoon, J., Daneshgar, N., Chu, Y., Chen, B., Hefti, M. M., Vikram, A., Irani, K., Song, L., Brenner, C., Abel, E. D., et al. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.954 · Cited by 37
Self-citationControl of NAD+ homeostasis by autophagic flux modulates mitochondrial and cardiac function
Zhang, Q., Li, Z., Li, Q., Trammell, S. A. J., Schmidt, M. S., Pires, K. M. P., Cai, J., Zhang, Y., Kenny, H., Boudina, S., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-023-00009-w · Cited by 40
“The NAD + levels and its related metabolites were measured using LC-MS methods as described in previous studies (Trammell et al, 2016a, 2016b).”
InfluentialSelf-citationPyridine Dinucleotides from Molecules to Man
Fessel, J. P., & Oldham, W. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7120 · Cited by 38
“Nicotinamide riboside appears to be effective for increasing intracellular NAD in murine models and likely in humans as well when supplemented in the diet (231).”
Dopamine Triggers CTCF-Dependent Morphological and Genomic Remodeling of Astrocytes
Galloway, A. L., Adeluyi, A., O’Donovan, B., Fisher, M. L., Rao, C. N., Critchfield, P., Sajish, M., Turner, J. R., & Ortinski, P. I. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3349-17.2018 · Cited by 41
“…for CTCF, commonly used NAD precursors, nicotinamide and nicotinamide riboside, exhibit opposite effects on PARP1 activity due to their disparate effects on SIRT1, the negative regulator of PARP1 (Bitterman et al., 2002; Rajamohan et al., 2009; Sajish and Schimmel, 2015; Trammell et al., 2016).”
BackgroundMitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies
Djouadi, F., & Bastin, J. (2019) · Cells · doi:10.3390/cells8040289 · Cited by 37
“showed that a single NR oral administration of 100, 300, or 1000 mg to 12 healthy women and men, significantly increased blood NAD+ without serious adverse effects [246], and most relevant to mitochondrial disorders, two weeks of acipimox treatment, a nicotinic acid analog, was reported to significantly increase mitoc…”
BackgroundThe Potential Use of Metabolic Cofactors in Treatment of NAFLD
Mardinoğlu, A., Ural, D., Zeybel, M., Yuksel, H. H., Uhlén, M., & Borén, J. (2019) · Nutrients · doi:10.3390/nu11071578 · Cited by 37
“determined the time and dose-dependent effects of NR on blood NAD+ level in humans [39].”
BackgroundZhang, M., Du, W., Acklin, S., Jin, S., & Xia, F. (2020) · Journal of Clinical Investigation · doi:10.1172/jci123159 · Cited by 41
“Interestingly, nicotinamide riboside, a precursor of NAD+ and activator of SIRT1 and SIRT2, has been shown to alleviate paclitaxel-induced peripheral neuropathy independently of DNA damage repair (38).”
BackgroundInfluentialHu, G., Ling, C., Chi, L., Thind, M. K., Furse, S., Koulman, A., Swann, J. R., Lee, D., Calon, M. M., Bourdon, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35317-y · Cited by 43
Targeting epigenetics: A novel promise for Alzheimer’s disease treatment
Jeremic, D., Jiménez‐Díaz, L., & Navarro‐López, J. D. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102003 · Cited by 39
Roseburia hominis improves host metabolism in diet-induced obesity
Huang, W., Zhu, W., Lin, Y., Chan, F. K. L., Xu, Z., & Ng, S. C. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2467193 · Cited by 41
“51 Previous studies showed that the supplementation of nicotinamide riboside could attenuate age-associated metabolic and functional changes in hematopoietic stem cells.”
The Emerging Role of Energy Metabolism and Neuroprotective Strategies in Parkinson's Disease
Błaszczyk, J. W. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00301 · Cited by 35
Tanamai, J., Veeramanomai, S., & Indrakosas, N. (2004) · PubMed · Cited by 35
Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase
Mizuno, R., Hojo, H., Takahashi, M., Kashio, S., Enya, S., Nakao, M., Konishi, R., Yoda, M., Harata, A., Hamanishi, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30926-z · Cited by 34
Connell, N., Grevendonk, L., Fealy, C., Moonen-Kornips, E., Bruls, Y., Schrauwen-Hinderling, V., de Vogel, J., Hageman, R., Geurts, J., Zapata-Perez, R., et al. (2021) · The Journal of Nutrition · doi:10.1093/jn/nxab193 · Cited by 33
“Here, we did not observe an increase in metabolites belonging to the kynurenine pathway from L-Trp to QA and subsequently to NAAD, a suggested sensitive biomarker of NAD+-precursor supplementation efficacy (55).”
BackgroundLeung, C. K.-S., Ren, S. T., Chan, P. P. M., Wan, K. H.-N., Kam, A. K. W., Lai, G. W. K., Chiu, V. S. M., Ko, M. W. L., Yiu, K. F. C., & Yu, M. (2022) · Trials · doi:10.1186/s13063-021-05968-1 · Cited by 38
“Increasing evidence has shown that axon degeneration is associated with a decline in NAD and that supplementation of NAD or NAD precursors is effective to delay axon degeneration in vitro and in vivo [7–10].”
BackgroundInfluentialNicotinamide Adenine Dinucleotide: The Redox Sensor in Aging-Related Disorders
Schiuma, G., Lara, D., Clement, J. P., Narducci, M., & Rizzo, R. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0375 · Cited by 40
Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model
Joshi, U., Evans, J. E., Pearson, A., Saltiel, N. A., Cseresznye, A., Darcey, T. S., Ojo, J. O., Keegan, A. P., Oberlin, S., Mouzon, B., et al. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.04.006 · Cited by 36
Molecular hallmarks of ageing in amyotrophic lateral sclerosis
Jagaraj, C. J., Shadfar, S., Kashani, S. A., Saravanabavan, S., Farzana, F., & Atkin, J. D. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05164-9 · Cited by 42
Morifuji, M., Higashi, S., Ebihara, S., & Nagata, M. (2024) · GeroScience · doi:10.1007/s11357-024-01204-1 · Cited by 49
Syntheses and chemical properties of β-nicotinamide riboside and its analogues and derivatives
Makarov, M. V., & Migaud, M. E. (2019) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.15.36 · Cited by 33
Self-citationAgeing and longevity genes in cardiovascular diseases
Liberale, L., Kraler, S. C., Camici, G. G., & Lüscher, T. F. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13426 · Cited by 35
Non-canonical roles of NAMPT and PARP in inflammation
Martínez-Morcillo, F. J., Cantón-Sandoval, J., Martínez‐Menchón, T., Corbalán-Vélez, R., Mesa-del-Castillo, P., Pérez‐Oliva, A. B., García‐Moreno, D., & Mulero, V. (2020) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2020.103881 · Cited by 35
Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication
Lauritzen, K. H., Olsen, M. B., Ahmed, M. S., Yang, K., Rinholm, J. E., Bergersen, L. H., Esbensen, Q. Y., Sverkeli, L. J., Ziegler, M., Attramadal, H., et al. (2021) · eLife · doi:10.7554/elife.59828 · Cited by 34
“However, others have noted that it is difficult to achieve increase in NAD levels in heart tissue, possibly due to very high metabolic turnover (Trammell et al., 2016).”
BackgroundEsam, Z., Akhavan, M., Lotfi, M., & Bekhradnia, A. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131394 · Cited by 31
Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases
Rotllán, N., Camacho, M., Tondo, M., Diarte‐Añazco, E. M. G., Canyelles, M., Méndez‐Lara, K. A., Benítez, S., Alonso, N., Mauricio, D., Escolá‐Gil, J. C., et al. (2021) · Antioxidants · doi:10.3390/antiox10121939 · Cited by 34
“Single doses of 100, 300 and 1000 mg of NR produced dose-dependent increases in the blood NAD+ metabolome [54].”
BackgroundNAD + Precursors in Human Health and Disease: Current Status and Future Prospects
Yaku, K., & Nakagawa, T. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0354 · Cited by 33
“…NR has been shown to increase levels of dea-midated NAD + metabolites such as NAR and NAAD in whole blood, PBMCs, urine, and skeletal muscle (Brakedal et al., 2022; Dollerup et al., 2018; Elhassan et al., 2019; Jensen et al., 2022; Remie et al., 2020; Stocks et al., 2021; Trammell et al., 2016a).”
InfluentialLaunay, J., Delorme, R., Pagan, C., Callebert, J., Leboyer, M., & Vodovar, N. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02687-w · Cited by 35
“Plasma NAD + , oxytocin and stanniocalcin-2 (STC2) measurements NAD + concentrations were determined by LC-MS as described previously [35].”
MethodYao, L., Wu, Y., Zhuang, W., Zhao, H., Nie, W., Wu, G., Pang, D., & Xie, H.-Y. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01402-y · Cited by 42
“…and nicotinamide 14,15 , which are limited in terms of the low NAD + augment efficiency 16,17 , concerns regarding side effect 12,18 and the need for high-dose administration (400 mg kg −1 nicotinamide riboside in mice, corresponding to 28 g for a 70 kg adult) 15,19–21 (Supplementary Table 1).”
Nicotinamide riboside induces a thermogenic response in lean mice
Crisol, B., Veiga, C. B., Lenhare, L., Braga, R. R., Silva, V. R. R., da Silva, A. S. R., Cintra, D. E., de Moura, L. P., Pauli, J. R., & Ropelle, E. R. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.015 · Cited by 32
Fasting‐ and ghrelin‐induced food intake is regulated by NAMPT in the hypothalamus
de Guia, R. M., Hassing, A. S., Skov, L. J., Ratner, C., Plucińska, K., Madsen, S., Diep, T. A., Cruz, G. V. D., Trammell, S. A. J., Sustarsic, E. G., et al. (2020) · Acta Physiologica · doi:10.1111/apha.13437 · Cited by 32
Self-citationTargeting Cardiovascular Risk Factors Through Dietary Adaptations and Caloric Restriction Mimetics
Voglhuber, J., Ljubojević-Holzer, S., Abdellatif, M., & Sedej, S. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.758058 · Cited by 35
Fang, J., Wu, H., Zhang, J., Mao, S., Shi, H., Yu, D., Chen, Z., Su, K., Xing, Y., Dong, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113071 · Cited by 31
Wu, R., Zhang, F., Liu, L., Li, W., Pichersky, E., & Wang, G. (2018) · Molecular Plant · doi:10.1016/j.molp.2018.07.003 · Cited by 30
A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder
Szot, J. O., Cuny, H., Martin, E. M. M. A., Sheng, D. Z., Iyer, K. R., Portelli, S., Nguyen, V., Gereis, J. M., Alankarage, D., Chitayat, D. A., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci174824 · Cited by 35
“…pathway in plasma and whole blood, suggesting that these might be good biomarkers for NADSYN1-dependent CNDD. NaAD is not detectable in healthy human blood and thus has only been reported as a biomarker of the NAD-boosting supplement NR, when systemic NAD levels are already sufficiently high (34).”
BackgroundNAD+ precursor supplementation in human ageing: clinical evidence and challenges
Vinten, K. T., Trętowicz, M. M., Coskun, E., van Weeghel, M., Cantó, C., Perez, R. Z., Janssens, G. E., & Houtkooper, R. H. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01387-7 · Cited by 44
“NAD + is likely to be absent in plasma, similar to other phosphorylated compounds such as NAMN, NAAD, NADP + , NMN and ADPR 78 .”
InfluentialTherapeutic potential of nicotinamide adenine dinucleotide (NAD)
Arenas‐Jal, M., Suñé-Negre, J. M., & García‐Montoya, E. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173158 · Cited by 36
New cases that expand the genotypic and phenotypic spectrum of Congenital NAD Deficiency Disorder
Szot, J. O., Slavotinek, A. M., Chong, K., Brandau, O., Nezarati, M. M., Cueto-González, A. M., Patel, M. S., Devine, W. P., Rego, S. M., Acyinena, A. P., et al. (2021) · Human Mutation · doi:10.1002/humu.24211 · Cited by 35
“…mononucleotide (Kim et al., 2020) have been shown to significantly bolster NAD synthesis via the de novo pathway via direct or indirect means, respectively, while nicotinamide riboside supplementation in humans has been documented with minimal adverse physiological outcomes (Trammell et al., 2016).”
BackgroundHost NAD+ metabolism and infections: therapeutic implications
Singhal, A., & Cheng, C. Y. (2018) · International Immunology · doi:10.1093/intimm/dxy068 · Cited by 32
Wei, X., Jia, R., Wang, G., Hong, S., Song, L., Sun, B., Chen, K., Wang, N., Wang, Q., Luo, X. M., et al. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108377 · Cited by 30
Parker, R., Schmidt, M. S., Cain, O. L., Gunson, B. K., & Brenner, C. (2020) · Hepatology Communications · doi:10.1002/hep4.1530 · Cited by 32
“The liver has the potential not only to produce NAD coenzymes but also to circulate NAD precursors to other tissues.(33,34) In this regard, it was interesting that levels of NA were strikingly depressed in liver diseases.”
BackgroundSelf-citationCan nicotinamide riboside protect against cognitive impairment?
Braidy, N., & Liu, Y. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000691 · Cited by 29
Poljšak, B., Kovač, V., & Milisav, I. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8819627 · Cited by 36
Metabolic needs of the kidney graft undergoing normothermic machine perfusion
Arykbaeva, A. S., de Vries, D. K., Doppenberg, J. B., Engelse, M. A., Hankemeier, T., Harms, A. C., Wijermars, L. G. M., Schaapherder, A. F., Bakker, J. A., Ploeg, R. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.04.001 · Cited by 32
NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies
Loreto, A., Antoniou, C., Merlini, E., Gilley, J., & Coleman, M. P. (2023) · Neuroscience Research · doi:10.1016/j.neures.2023.01.004 · Cited by 32
“Data from clinical trials suggest that supplementation with NAD precursors in humans leads to changes in NAD metabolism which are compatible with an increase in both the rate of NAD synthesis and consumption (Trammell et al. 2016; Brakedal et al. 2022; Okabe et al. 2022).”
Nicotinamide riboside regulates inflammation and mitochondrial markers in AML12 hepatocytes
Lee, H. J., & Yang, S. J. (2019) · Nutrition Research and Practice · doi:10.4162/nrp.2019.13.1.3 · Cited by 34
“NR may break down to NAM by purine nucleoside phosphorylase [2].”
BackgroundInfluentialMitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension
Dikalov, S., & Dikalova, A. (2021) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000771 · Cited by 28
“supplementation with NADþ precursor nicotinamide riboside [20].”
Optimization of NAMPT activators to achieve in vivo neuroprotective efficacy
Wang, L., Liu, M., Zu, Y., Hong, Y., Wu, C., Zhang, R., Ma, W., Lu, H., Xi, S., Liu, Y., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114260 · Cited by 30
NAD metabolism in aging and cancer
Kincaid, J. W. R., & Berger, N. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220929287 · Cited by 31
“A phosphorylated analogue of NAD, NADP is synthesized by NAD kinases (NADK), which transfer a phosphate from ATP to the 20-hydroxyl group on the ribose portion of NAD.51 NADK has also shown high selectivity towards its substrates ATP and NAD, as well as the use of Ca2þ, Mg2þ, and Mn2þ as cofactors, mechanisms originat…”
BackgroundInfluentialNicotinamide and acute kidney injury
Fontecha‐Barriuso, M., López-Diaz, A. M., Carriazo, S. M., Ortíz, A., & Sanz, A. B. (2021) · Clinical Kidney Journal · doi:10.1093/ckj/sfab173 · Cited by 28
“Single doses of 100, 300 and 1000 mg of NR led to dose-dependent increases in the blood NADþ metabolome [23].”
BackgroundPurine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells
Kropotov, A., Kulikova, V., Solovjeva, L., Yakimov, A. P., Nerinovski, K., Svetlova, M., Sudnitsyna, J. S., Plusnina, A., Antipova, M., Khodorkovskiy, M., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102615 · Cited by 31
“Our data are consistent with the observations of other researchers, according to which intraperitoneal injections of NR into mice at different doses (from 50 to 500 mg/kg) caused a significant accumulation of Nam in plasma and liver, while no significant accumulation of NR was observed (42, 46, 47).”
ResultSelf-citationMishra, S., Welch, N., Karthikeyan, M., Bellar, A., Musich, R. J., Singh, S. S., Zhang, D., Sekar, J., Attaway, A. H., Chelluboyina, A. K., et al. (2023) · Aging Cell · doi:10.1111/acel.13852 · Cited by 29
“sirtuin 3 expression and reverses hyperacetylation In contrast to the previously reported beneficial effects of NR by others (Canto et al., 2012; Trammell et al., 2016), we did not observe F I G U R E 3 Overexpression of NADH oxidase reverses redox dependent protein acetylation during…”
BackgroundMethodChu, D., & Tao, Y. (2016) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-016-0536-y · Cited by 29
“Then, in the early of this month, one article was released reporting the first human clinical trial for NR; it showed that NR increased levels of a cell metabolite critical for cellular energy production without any serious side effects [24].”
BackgroundMitochondrial Dysfunction: A New Hallmark in Hereditable Thoracic Aortic Aneurysm Development
Marcos-Ríos, D., Rochano-Ortiz, A., Sebastián-Jaraba, I. S., Fernández-Gómez, M. J., Méndez‐Barbero, N., & Oller, J. (2025) · Cells · doi:10.3390/cells14080618 · Cited by 28
“Some NAD+-boosting strategies include the direct supplementation of NAD+ precursors [10,135], the stimulation of enzymes involved in the synthesis of NAD + [136], and the prevention of the escape of intermediates from the NAD+ biosynthetic pathway [133].”
InfluentialPliouta, L., Lampsas, S., Kountouri, A., Korakas, E., Thymis, J., Kassi, E. N., Oikonomou, E. K., Ikonomidis, I., & Lambadiari, V. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113706 · Cited by 34
“In HFpEF, altered TCA cycle enzyme activity has been linked to protein hyperacetylation that impairs the function of key TCA cycle enzymes, further exacerbating metabolic inefficiency [95].”
Aryl hydrocarbon receptor (AHR) functions in NAD+ metabolism, myelopoiesis and obesity
Bock, K. W. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.02.021 · Cited by 27
Blood NAD levels are reduced in very old patients hospitalized for heart failure
Breton, M., Costemale-Lacoste, J.-F., Li, Z., Lafuente‐Lafuente, C., Belmin, J., & Mericskay, M. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111051 · Cited by 30
Self-citationLee, S. R., ROH, J., Ryu, J., Shin, H., & Hong, E. (2022) · Cell & Bioscience · doi:10.1186/s13578-021-00740-z · Cited by 29
“According to previous literature, NAD+ level was suggested to be inversely correlated to SARS-CoV-2 induced death as elderly people decreases NAD+ [47].”
InfluentialNAD+ Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
Chanvillard, L., Tammaro, A., & Sorrentino, V. (2022) · Cells · doi:10.3390/cells12010021 · Cited by 29
Vitamin B3 forms as precursors to NAD+: Are they safe?
Poljšak, B., & Milisav, I. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.07.020 · Cited by 30
Zhang, X., Henneman, N. F., Girardot, P. E., Sellers, J. T., Chrenek, M. A., Li, Y., Wang, J., Brenner, C., Nickerson, J. M., & Boatright, J. H. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.10.47 · Cited by 27
Self-citationThe Biochemical Pathways of Nicotinamide-Derived Pyridones
Hayat, F., Sonavane, M., Makarov, M. V., Trammell, S. A. J., McPherson, P., Gassman, N. R., & Migaud, M. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031145 · Cited by 25
Self-citation
Metadata
- Authors
- Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Queen's University Belfast (GB)
- ChromaDex (United States) (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-10
- Volume
- 7
- Issue
- 1
- Pages
- 12948-12948
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5062546
- OpenAlex
- W2530388030
- Cited by
- 697
- References
- 57
- Citations by year
- 2026: 73 · 2025: 72 · 2024: 63 · 2023: 73 · 2022: 80 · 2021: 89 · 2020: 73 · 2019: 70 · 2018: 58 · 2017: 40 · 2016: 2
- FWCI
- 32.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- Roy J. Carver Charitable Trust
- National Institutes of Health
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/N001842/1)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Heart, Lung, and Blood Institute (R01HL108379)
- National Institute of General Medical Sciences (T32GM008629)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- nicotinamide riboside, NAD+ metabolism, oral bioavailability, pharmacokinetics, nicotinic acid, nicotinamide, dose-dependent effects
- MeSH terms
- Administration, Oral, Animals, Biological Availability, Humans, Leukocytes, Mononuclear, Liver, Male, Mice, Inbred C57BL, Middle Aged, NAD, Niacinamide, Pyridinium Compounds, Vitamins, Biomarkers, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.